Kenvue Inc. (KVUE NYSE) stock market data APIs
$21.0352
-0.13(-0.6%)
as of July 1, 2025
Try our APIs with
free plan!
Kenvue Inc. Financial Data Overview
Price chart is built with
Anychart
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Prev. Close
21.0352
Open
20.9029
High
21.4394
Low
21.0747
52 wk Range
17.0297-24.9519
Market Cap
40 184 M
P/E Ratio
37.375
Shares Outstanding
1 920 M
Revenue
15 302 M
EPS
0.24
Dividends (Yield)
0.0392
Beta
0.925
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Kenvue Inc. data using free add-ons & libraries
Get Kenvue Inc. Fundamental Data
Kenvue Inc. Fundamental data includes:
- Net Revenue: 15 302 M
- EBITDA: 3 509 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-08
- EPS/Forecast: 0.23
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Kenvue Inc. News
New
Why JNJ Is a Long-Term Winner
Johnson & Johnson (NYSE:JNJ) is one of the Best Wide Moat Dividend Stocks to Invest in.Why JNJ Is a Long-Term Winner A smiling baby with an array of baby care products in the foreground. Johnson & J...
Guru Fundamental Report for KVUE
Below is Validea's guru fundamental report for KENVUE INC (KVUE). Of the 22 guru strategies we follow, KVUE rates highest using our Earnings Yield Investor model based on the published strategy of Jo...
Noteworthy Thursday Option Activity: GS, KVUE, AMD
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Goldman Sachs Group Inc (Symbol: GS), where a total of 43,937 contracts have traded so far, repr...
Kenvue Releases Second Annual Healthy Lives Mission Report Highlighting Progress in Reducing Emissions and Advancing More Sustainable Product Innovation
Company reports reduction of operational emissions by 37%, expanded use of renewable electricity to 72% and launch of multiple packaging innovations across portfolio NORTHAMPTON, MA / ACCESS Newswire...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
